ProAir RespiClick Approval History
- FDA approved: Yes (First approved March 31st, 2015)
- Brand name: ProAir RespiClick
- Generic name: albuterol sulfate
- Dosage form: Inhalation Powder
- Company: Teva Pharmaceutical Industries Ltd.
- Treatment for: Asthma
ProAir RespiClick (albuterol sulfate) is a breath-actuated, dry-powder, short-acting beta-agonist (SABA) inhaler for the relief of acute asthma symptoms.
Development History and FDA Approval Process for ProAir RespiClick
|Apr 29, 2016||Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11|
|Apr 1, 2015||Teva Announces FDA Approval of ProAir RespiClick|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.